Congress Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.7M	Sell	94,417 -1,897	-2%	-$216K	0.1%	232
2025 Q1	$10.1M	Buy	96,314 +1,979	+2%	+$208K	0.12%	200
2024 Q4	$10.1M	Buy	94,335 +4,014	+4%	+$430K	0.14%	199
2024 Q3	$9.04M	Buy	90,321 +2,071	+2%	+$207K	0.12%	226
2024 Q2	$7.44M	Buy	+88,250	New	+$7.44M	0.12%	206